Asset
Deramiocel
Capricor Therapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT03406780 | phase2 | completed | 2018-04-04 | 2020-03-10 | Capricor Inc. | A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy |
| NCT04623671 | phase2 | completed | 2020-11-15 | 2022-02-04 | Capricor Inc. | Intravenous Infusion of CAP-1002 in Patients With COVID-19 |
FDA applications (0)
This company has no applications containing this asset.